Response to dexamethasone in patients with fluid retention after docetaxel
- 1 May 1996
- journal article
- Published by Elsevier in The Lancet
- Vol. 347 (9013) , 1486-1487
- https://doi.org/10.1016/s0140-6736(96)91723-7
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.Journal of Clinical Oncology, 1996
- Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.Journal of Clinical Oncology, 1995
- Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.Journal of Clinical Oncology, 1995